Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis
暂无分享,去创建一个
M. Pillon | A. Reiter | Angelo Rosolen | M. Zimmermann | G. Franceschetto | L. Mussolin | C. Damm-Welk | W. Woessmann | K. Pulford | M. Zimmermann